Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             399 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins Kissel, Thomas
 2002
 82-83 1 p. 99-134
36 p.
 artikel
2 ABCG2: A perspective Robey, Robert W.
 2009
 82-83 1 p. 3-13
11 p.
 artikel
3 Active secretion and enterocytic drug metabolism barriers to drug absorption Wacher, Vincent J.
 1996
 82-83 1 p. 99-112
14 p.
 artikel
4 Active targeting with particulate carrier systems in the blood compartment Crommelin, D.J.A.
 1995
 82-83 1 p. 49-60
12 p.
 artikel
5 Addendum to “Photosensitizer delivery for photodynamic therapy of choroidal neovascularization” Renno, Reem Z
 2001
 82-83 1 p. 131-
1 p.
 artikel
6 Adeno-associated virus as a gene delivery system During, Matthew J
 1997
 82-83 1 p. 83-94
12 p.
 artikel
7 Advanced drug delivery devices via self-assembly of amphiphilic block copolymers Rösler, Annette
 2001
 82-83 1 p. 95-108
14 p.
 artikel
8 Advanced Drug Delivery Reviews (ADDR) is poised to embark on its second quarter of a century 2012
 82-83 1 p. vi-
1 p.
 artikel
9 Advanced Drug Delivery Reviews Cornerstone in the stimulation and dissemination of innovative drug delivery research Lee, Vincent H.L.
 2004
 82-83 1 p. 1-2
2 p.
 artikel
10 Advanced materials and processing for drug delivery: The past and the future Zhang, Ying
 2013
 82-83 1 p. 104-120
17 p.
 artikel
11 Advanced microscopy solutions for monitoring the kinetics and dynamics of drug–DNA targeting in living cells Errington, R.J.
 2005
 82-83 1 p. 153-167
15 p.
 artikel
12 Advances in fluorescence imaging: opportunities for pharmaceutical science Jepson, Mark A.
 2005
 82-83 1 p. 1-4
4 p.
 artikel
13 Aerosol particle transport and deaggregation phenomena in the mouth and throat Li, Wen-I
 1997
 82-83 1 p. 41-49
9 p.
 artikel
14 Airway-to-biophase transfer of inhaled oligonucleotides Wu-Pong, Susanna
 1996
 82-83 1 p. 47-71
25 p.
 artikel
15 Alternative interpretations of the oligonucleotide transport literature: insights from nature Wu-Pong, Susanna
 2000
 82-83 1 p. 59-70
12 p.
 artikel
16 A magnificent journey Lee, Vincent H.L.
 2012
 82-83 1 p. v-
1 p.
 artikel
17 Amorphous pharmaceutical solids: preparation, characterization and stabilization Yu, Lian
 2001
 82-83 1 p. 27-42
16 p.
 artikel
18 Analysis of polypeptides and proteins Jones, Andrew J.S.
 1993
 82-83 1 p. 29-90
62 p.
 artikel
19 Announcement 2004
 82-83 1 p. 3-
1 p.
 artikel
20 Announcement 2004
 82-83 1 p. I-II
nvt p.
 artikel
21 Anti-cancer PEG-enzymes: 30 years old, but still a current approach Pasut, Gianfranco
 2008
 82-83 1 p. 69-78
10 p.
 artikel
22 Application of DNA vaccine technology to aquaculture Heppell, Joël
 2000
 82-83 1 p. 29-43
15 p.
 artikel
23 Application of membrane-active peptides for drug and gene delivery across cellular membranes Plank, Christian
 1998
 82-83 1 p. 21-35
15 p.
 artikel
24 Applications of genetic engineering in veterinary medicine Ciftci, Kadriye
 2000
 82-83 1 p. 57-64
8 p.
 artikel
25 Applications of imaging techniques to studies of epithelial tight junctions Johnson, Larry G.
 2005
 82-83 1 p. 111-121
11 p.
 artikel
26 A practical assessment of transdermal drug delivery by skin electroporation Prausnitz, Mark R
 1999
 82-83 1 p. 61-76
16 p.
 artikel
27 A scintigraphic study to evaluate the deposition patterns of a novel anti-asthma drug inhaled from the Cyclohaler dry powder inhaler Pitcairn, G.R
 1997
 82-83 1 p. 59-67
9 p.
 artikel
28 Assuring quality of drugs by monitoring impurities Ahuja, Satinder (Sut)
 2007
 82-83 1 p. 3-11
9 p.
 artikel
29 Basic study for stabilization of w/o/w emulsion and its application to transcatheter arterial embolization therapy Hino, T
 2000
 82-83 1 p. 27-45
19 p.
 artikel
30 Binding and entry of animal viruses Sommerfelt, Maja A.
 1989
 82-83 1 p. 1-26
26 p.
 artikel
31 Bioadhesive and phase-change polymers for ocular drug delivery Robinson, Joseph R.
 1995
 82-83 1 p. 45-50
6 p.
 artikel
32 Biodegradable block copolymers Kumar, Neeraj
 2001
 82-83 1 p. 23-44
22 p.
 artikel
33 Biodegradable implant strategies for inhibition of restenosis Orloff, Lisa A.
 1997
 82-83 1 p. 3-9
7 p.
 artikel
34 Biodegradable microspheres for vitreoretinal drug delivery Herrero-Vanrell, Rocio
 2001
 82-83 1 p. 5-16
12 p.
 artikel
35 Biodegradable scleral plugs for vitreoretinal drug delivery Yasukawa, T
 2001
 82-83 1 p. 25-36
12 p.
 artikel
36 Biodegradation and biocompatibility of PLA and PLGA microspheres Anderson, James M
 1997
 82-83 1 p. 5-24
20 p.
 artikel
37 Biodegradation, biodistribution and toxicity of chitosan Kean, T.
 2010
 82-83 1 p. 3-11
9 p.
 artikel
38 Biomolecule-sensitive hydrogels Miyata, Takashi
 2002
 82-83 1 p. 79-98
20 p.
 artikel
39 Block copolymer micelles for drug delivery: design, characterization and biological significance Kataoka, Kazunori
 2001
 82-83 1 p. 113-131
19 p.
 artikel
40 Cancer nanomedicines: So many papers and so few drugs! Venditto, Vincent J.
 2013
 82-83 1 p. 80-88
9 p.
 artikel
41 Carrier-mediated approaches for oral drug delivery Tamai, Ikumi
 1996
 82-83 1 p. 5-32
28 p.
 artikel
42 Catheter-based drug delivery for restenosis Eccleston, David S.
 1997
 82-83 1 p. 31-43
13 p.
 artikel
43 Cationic lipids used in gene transfer Zabner, Joseph
 1997
 82-83 1 p. 17-28
12 p.
 artikel
44 Cell biology and active transport processes in the colon Hastewell, John
 1991
 82-83 1 p. 119-147
29 p.
 artikel
45 Cell cycle regulation and control of angioplasty restenosis Welt, Frederick G.P.
 1997
 82-83 1 p. 45-51
7 p.
 artikel
46 Challenges in pediatric drug delivery: the case of vaccines Fasano, Alessio
 2006
 82-83 1 p. 1-3
3 p.
 artikel
47 Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations Buckton, Graham
 1997
 82-83 1 p. 17-27
11 p.
 artikel
48 Characterization of the solid state: quantitative issues Stephenson, Gregory A.
 2001
 82-83 1 p. 67-90
24 p.
 artikel
49 Characterization of the solid-state: spectroscopic techniques Bugay, David E.
 2001
 82-83 1 p. 43-65
23 p.
 artikel
50 Chemical reactivity in solid-state pharmaceuticals: formulation implications Byrn, Stephen R
 2001
 82-83 1 p. 115-136
22 p.
 artikel
51 Chitosan-based delivery systems for protein therapeutics and antigens Amidi, Maryam
 2010
 82-83 1 p. 59-82
24 p.
 artikel
52 Chitosan-based formulations for delivery of DNA and siRNA Mao, Shirui
 2010
 82-83 1 p. 12-27
16 p.
 artikel
53 Chitosan-based formulations of drugs, imaging agents and biotherapeutics Amidi, Maryam
 2010
 82-83 1 p. 1-2
2 p.
 artikel
54 Chitosan-based hydrogels for controlled, localized drug delivery Bhattarai, Narayan
 2010
 82-83 1 p. 83-99
17 p.
 artikel
55 Chitosan-based nanostructures: A delivery platform for ocular therapeutics de la Fuente, Maria
 2010
 82-83 1 p. 100-117
18 p.
 artikel
56 Chitosan-based systems for molecular imaging Agrawal, Prashant
 2010
 82-83 1 p. 42-58
17 p.
 artikel
57 Chronopharmacology of growth hormone and related peptides Robinson, I.C.A.F.
 1991
 82-83 1 p. 57-82
26 p.
 artikel
58 Chronotherapy of cancer: a major drug-deliver challenge Hrushesky, William J.M.
 1992
 82-83 1 p. 1-83
83 p.
 artikel
59 Clinical applications of electrochemotherapy Heller, Richard
 1999
 82-83 1 p. 119-129
11 p.
 artikel
60 Clinical investigation of gut immune responses Ferguson, Anne
 1995
 82-83 1 p. 53-71
19 p.
 artikel
61 Clinical trials in pediatrics: The drug delivery dimension Osuntokun, Bankole
 2006
 82-83 1 p. 90-105
16 p.
 artikel
62 (C) Means to enhance penetration Shen, Wei-Chiang
 1992
 82-83 1 p. 93-113
21 p.
 artikel
63 (C) Means to enhance penetration Scott Swenson, E.
 1992
 82-83 1 p. 39-92
54 p.
 artikel
64 (C) Means to enhance penetration Bundgaard, Hans
 1992
 82-83 1 p. 1-38
38 p.
 artikel
65 (C) Means to Enhance Penetration Bhaskar Kompella, Udaya
 1992
 82-83 1 p. 115-162
48 p.
 artikel
66 Colon-specific drug delivery Friend, David R.
 1991
 82-83 1 p. 149-199
51 p.
 artikel
67 Combinatorial chemistry and biomedical polymer development Brocchini, S
 2001
 82-83 1 p. 123-130
8 p.
 artikel
68 Coming out of the dark: the evolving role of fluorescence imaging in drug delivery research Gumbleton, Mark
 2005
 82-83 1 p. 5-15
11 p.
 artikel
69 Comparative placental structure Enders, Allen C
 1999
 82-83 1 p. 3-15
13 p.
 artikel
70 Conditionally replicative adenoviruses for cancer therapy Rancourt, Claudine
 1997
 82-83 1 p. 67-81
15 p.
 artikel
71 Considerations in the design and development of transport inhibitors as adjuncts to drug therapy Dantzig, Anne H
 2003
 82-83 1 p. 133-150
18 p.
 artikel
72 Contents erratum 1995
 82-83 1 p. 113-
1 p.
 artikel
73 Control of tumour vascular permeability Baban, Dilair F
 1998
 82-83 1 p. 109-119
11 p.
 artikel
74 Corrigendum to “Optimization, evaluation, and characterization of molecularly imprinted polymers” [Advanced Drug Delivery Reviews 57 (2005) 1779-1794] Spivak, David A.
 2006
 82-83 1 p. 116-
1 p.
 artikel
75 Crystalline solids Vippagunta, Sudha R.
 2001
 82-83 1 p. 3-26
24 p.
 artikel
76 Current status of DNA vaccines in veterinary medicine Krishnan, B.Rajendra
 2000
 82-83 1 p. 3-11
9 p.
 artikel
77 Cyclodextrin-based controlled drug release system Hirayama, F
 1999
 82-83 1 p. 125-141
17 p.
 artikel
78 Cyclodextrins in nasal drug delivery Merkus, F.W.H.M
 1999
 82-83 1 p. 41-57
17 p.
 artikel
79 Cyclodextrins in ophthalmic drug delivery Loftssona, Thorsteinn
 1999
 82-83 1 p. 59-79
21 p.
 artikel
80 Cyclodextrins in peptide and protein delivery Irie, Tetsumi
 1999
 82-83 1 p. 101-123
23 p.
 artikel
81 Cyclodextrins in targeting Duchêne, Dominique
 1999
 82-83 1 p. 29-40
12 p.
 artikel
82 Cyclodextrins in transdermal and rectal delivery Matsuda, Hajime
 1999
 82-83 1 p. 81-99
19 p.
 artikel
83 Delivery of antimicrobials to infected tissue macrophages Bakker-Woudenberg, Irma A.J.M.
 1995
 82-83 1 p. 5-20
16 p.
 artikel
84 Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis Wagner, Ernst
 1994
 82-83 1 p. 113-135
23 p.
 artikel
85 Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor Li, Yinghuan
 2012
 82-83 1 p. 29-39
11 p.
 artikel
86 Delivery of photosensitizers in photodynamic therapy van Nostrum, Cornelus F.
 2004
 82-83 1 p. 5-6
2 p.
 artikel
87 Delivery of photosensitizing agents Kessel, David
 2004
 82-83 1 p. 7-8
2 p.
 artikel
88 Delivery systems for intraocular routes Peyman, Gholam A.
 1995
 82-83 1 p. 107-123
17 p.
 artikel
89 Delivery systems for non-parenteral vaccines Li Wan Po, A.
 1995
 82-83 1 p. 101-109
9 p.
 artikel
90 Descriptors of irregular particle morphology and powder properties Hickey, Anthony J
 1997
 82-83 1 p. 29-40
12 p.
 artikel
91 Design of nanoparticles composed of graft copolymers for oral peptide delivery Sakuma, Shinji
 2001
 82-83 1 p. 21-37
17 p.
 artikel
92 Design of synthetic peptides for oral vaccination Meloen, R.H.
 1995
 82-83 1 p. 91-100
10 p.
 artikel
93 Devices for overcoming biological barriers: The use of physical forces to disrupt the barriers Mitragotri, Samir
 2013
 82-83 1 p. 100-103
4 p.
 artikel
94 Dextran prodrugs — structure and stability in relation to therapeutic activity Larsen, Claus
 1989
 82-83 1 p. 103-154
52 p.
 artikel
95 Disposition characteristics of emulsions and incorporated drugs after systemic or local injection Kawakami, Shigeru
 2000
 82-83 1 p. 77-88
12 p.
 artikel
96 Disulfide bridge based PEGylation of proteins Brocchini, Steve
 2008
 82-83 1 p. 3-12
10 p.
 artikel
97 DNA-based vaccination against hepatitis B virus Davis, Heather L.
 1996
 82-83 1 p. 33-47
15 p.
 artikel
98 DNA vaccination against malaria Doolan, Denise L.
 1996
 82-83 1 p. 49-61
13 p.
 artikel
99 Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung? McAllister, S.M.
 1996
 82-83 1 p. 89-110
22 p.
 artikel
100 Drug delivery to the posterior segments of the eye Ogura, Yuichiro
 2001
 82-83 1 p. 1-3
3 p.
 artikel
101 Drug–drug interaction mediated by inhibition and induction of P-glycoprotein Lin, Jiunn H
 2003
 82-83 1 p. 53-81
29 p.
 artikel
102 Drug efflux transporters in the CNS Sun, Haiying
 2003
 82-83 1 p. 83-105
23 p.
 artikel
103 Drugs of abuse and placental transport Ganapathy, Vadivel
 1999
 82-83 1 p. 99-110
12 p.
 artikel
104 Drug targeting to choroidal neovascularization Kimura, Hideya
 2001
 82-83 1 p. 79-91
13 p.
 artikel
105 Drug targeting to the kidney with low-molecular-weight proteins Franssen, Eric J.F.
 1994
 82-83 1 p. 67-88
22 p.
 artikel
106 Drug transport proteins in the liver Faber, Klaas Nico
 2003
 82-83 1 p. 107-124
18 p.
 artikel
107 Editorial 1999
 82-83 1 p. 1-2
2 p.
 artikel
108 Editorial 1999
 82-83 1 p. 1-2
2 p.
 artikel
109 Editorial 1998
 82-83 1 p. 1-2
2 p.
 artikel
110 Editorial Board 2009
 82-83 1 p. ii-
1 p.
 artikel
111 Editorial Board 2003
 82-83 1 p. ii-
1 p.
 artikel
112 Editorial Board 1995
 82-83 1 p. ii-
1 p.
 artikel
113 Editorial Board 1995
 82-83 1 p. ii-iii
nvt p.
 artikel
114 Editorial Board 1995
 82-83 1 p. ii-
1 p.
 artikel
115 Editorial Board 1997
 82-83 1 p. ii-
1 p.
 artikel
116 Editorial Board 1996
 82-83 1 p. ii-
1 p.
 artikel
117 Editorial Board 1996
 82-83 1 p. iii-
1 p.
 artikel
118 Editorial Board 1996
 82-83 1 p. ii-
1 p.
 artikel
119 Editorial Board 1997
 82-83 1 p. ii-
1 p.
 artikel
120 Editorial Board 1991
 82-83 1 p. ii-
1 p.
 artikel
121 Editorial Board 1994
 82-83 1 p. ii-
1 p.
 artikel
122 Editorial Board 2006
 82-83 1 p. ii-
1 p.
 artikel
123 Editorial Board 2004
 82-83 1 p. ii-
1 p.
 artikel
124 Editorial Board 2008
 82-83 1 p. ii-
1 p.
 artikel
125 Editorial Board 2005
 82-83 1 p. ii-
1 p.
 artikel
126 Editorial Board 2007
 82-83 1 p. ii-
1 p.
 artikel
127 Editorial Board 2010
 82-83 1 p. ii-
1 p.
 artikel
128 Editorial Board 2013
 82-83 1 p. ii-
1 p.
 artikel
129 Editorial Board 2012
 82-83 1 p. ii-
1 p.
 artikel
130 Editorial Board 1992
 82-83 1 p. iv-
1 p.
 artikel
131 Editorial Board 1991
 82-83 1 p. ii-
1 p.
 artikel
132 Editorial Board 1993
 82-83 1 p. ii-
1 p.
 artikel
133 Editorial Board 1992
 82-83 1 p. ii-
1 p.
 artikel
134 Editorial Board 1989
 82-83 1 p. iii-
1 p.
 artikel
135 Editorial Board 1989
 82-83 1 p. ii-
1 p.
 artikel
136 Editorial Board 1987
 82-83 1 p. iii-
1 p.
 artikel
137 Editorial Board 1988
 82-83 1 p. ii-
1 p.
 artikel
138 Effects of iontophoresis and electroporation on the stratum corneum Jadoul, Anne
 1999
 82-83 1 p. 89-105
17 p.
 artikel
139 Efflux transporters of the human placenta Young, Amber M
 2003
 82-83 1 p. 125-132
8 p.
 artikel
140 Electropermeabilization of cell membranes Teissié, J
 1999
 82-83 1 p. 3-19
17 p.
 artikel
141 Endocrine/reproductive pulsatile delivery systems Creasy, G.W.
 1991
 82-83 1 p. 51-56
6 p.
 artikel
142 Endothelial cell receptors Ryan, Una S.
 1989
 82-83 1 p. 65-85
21 p.
 artikel
143 Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI Taylor, June S.
 2000
 82-83 1 p. 91-110
20 p.
 artikel
144 Exploiting bone marrow microvascular structure for drug delivery and future therapies Moghimi, S.M.
 1995
 82-83 1 p. 61-73
13 p.
 artikel
145 Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors Beer, Steven J
 1997
 82-83 1 p. 59-66
8 p.
 artikel
146 Extravasation of macromolecules Takakura, Yoshinobu
 1998
 82-83 1 p. 93-108
16 p.
 artikel
147 Factors affecting short-term and long-term stabilities of proteins Arakawa, Tsutomu
 1993
 82-83 1 p. 1-28
28 p.
 artikel
148 Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions Juliano, R.L.
 1988
 82-83 1 p. 31-54
24 p.
 artikel
149 Fluorescence correlation spectroscopy of molecular motions and kinetics Gösch, Michael
 2005
 82-83 1 p. 169-190
22 p.
 artikel
150 Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate Torchilin, Vladimir P.
 2005
 82-83 1 p. 95-109
15 p.
 artikel
151 Fluorescence techniques for drug delivery research: theory and practice White, Nick S.
 2005
 82-83 1 p. 17-42
26 p.
 artikel
152 19F-MRS studies of fluorinated drugs in humans Wolf, Walter
 2000
 82-83 1 p. 55-74
20 p.
 artikel
153 Formulation of Neulasta® (pegfilgrastim) Piedmonte, Deirdre Murphy
 2008
 82-83 1 p. 50-58
9 p.
 artikel
154 Formulation of self-emulsifying drug delivery systems Pouton, Colin W.
 1997
 82-83 1 p. 47-58
12 p.
 artikel
155 Forthcoming articles 1993
 82-83 1 p. 131-133
3 p.
 artikel
156 Forthcoming articles 1992
 82-83 1 p. 113-
1 p.
 artikel
157 Forthcoming articles 1992
 82-83 1 p. 163-
1 p.
 artikel
158 Forthcoming articles 1994
 82-83 1 p. 153-
1 p.
 artikel
159 Forthcoming events 1991
 82-83 1 p. 219-
1 p.
 artikel
160 Forthcoming events 1992
 82-83 1 p. 115-118
4 p.
 artikel
161 Forthcoming events 1994
 82-83 1 p. 155-156
2 p.
 artikel
162 Forthcoming events 1992
 82-83 1 p. 164-
1 p.
 artikel
163 Forthcoming events 1993
 82-83 1 p. 135-137
3 p.
 artikel
164 Forthcoming events 1991
 82-83 1 p. 101-
1 p.
 artikel
165 Forthcoming events 1995
 82-83 1 p. 111-112
2 p.
 artikel
166 Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy Noguchi, Kohji
 2009
 82-83 1 p. 26-33
8 p.
 artikel
167 Functions of the human mononuclear phagocyte system (a condensed review) Becker, Susanne
 1988
 82-83 1 p. 1-29
29 p.
 artikel
168 Gastrointestinal lymphatic absorption of peptides and proteins Rubas, Werner
 1991
 82-83 1 p. 15-69
55 p.
 artikel
169 Gene-based therapies for restenosis Labhasetwar, Vinod
 1997
 82-83 1 p. 109-120
12 p.
 artikel
170 Gene targeting to the retina Sakamoto, Taiji
 2001
 82-83 1 p. 93-102
10 p.
 artikel
171 Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes Monsigny, Michel
 1994
 82-83 1 p. 1-24
24 p.
 artikel
172 Guide to Authors 2003
 82-83 1 p. 165-167
3 p.
 artikel
173 Guide to Authors 2002
 82-83 1 p. 163-165
3 p.
 artikel
174 Guide to Authors 2001
 82-83 1 p. 133-135
3 p.
 artikel
175 Guide to Authors 2006
 82-83 1 p. 117-121
5 p.
 artikel
176 Guide to Authors 2004
 82-83 1 p. 117-120
4 p.
 artikel
177 Guide to Authors 2005
 82-83 1 p. 211-214
4 p.
 artikel
178 Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsification technique Higashi, Shushi
 2000
 82-83 1 p. 57-64
8 p.
 artikel
179 Herpesvirus vaccines Babiuk, Lorne A.
 1996
 82-83 1 p. 63-76
14 p.
 artikel
180 Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development Szente, Lajos
 1999
 82-83 1 p. 17-28
12 p.
 artikel
181 Histidine-rich peptides and polymers for nucleic acids delivery Pichon, Chantal
 2001
 82-83 1 p. 75-94
20 p.
 artikel
182 Historical perspective on advanced drug delivery: How engineering design and mathematical modeling helped the field mature Peppas, Nicholas A.
 2013
 82-83 1 p. 5-9
5 p.
 artikel
183 How to improve exposure of tumor cells to drugs — Promoter drugs increase tumor uptake and penetration of effector drugs Marcucci, Fabrizio
 2012
 82-83 1 p. 53-68
16 p.
 artikel
184 Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza Shiver, John W.
 1996
 82-83 1 p. 19-31
13 p.
 artikel
185 Hydrogels for biomedical applications Hoffman, Allan S
 2002
 82-83 1 p. 3-12
10 p.
 artikel
186 Hydrogels for delivery of bioactive agents: A historical perspective Lee, Sang Cheon
 2013
 82-83 1 p. 17-20
4 p.
 artikel
187 Imaging living central neurones using viral gene transfer Teschemacher, A.G.
 2005
 82-83 1 p. 79-93
15 p.
 artikel
188 Imaging of oily formulations in the gastrointestinal tract Wilson, C.G.
 1997
 82-83 1 p. 91-101
11 p.
 artikel
189 Immobilised enzymes as drugs Torchilin, V.P.
 1987
 82-83 1 p. 41-86
46 p.
 artikel
190 Immunoconjugates and long circulating systems: Origins, current state of the art and future directions Koshkaryev, Alexander
 2013
 82-83 1 p. 24-35
12 p.
 artikel
191 Implications of chronopharmacokinetics for drug delivery: antiasthmatics, H2-blockers and cardiovascular active drugs Björn, Lemmer
 1991
 82-83 1 p. 83-100
18 p.
 artikel
192 Improving the prediction of the brain disposition for orally administered drugs using BDDCS Broccatelli, Fabio
 2012
 82-83 1 p. 95-109
15 p.
 artikel
193 Impurities in generic pharmaceutical development Kovaleski, John
 2007
 82-83 1 p. 56-63
8 p.
 artikel
194 Induction and characterization of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunization Haynes, Joel R.
 1996
 82-83 1 p. 3-18
16 p.
 artikel
195 Influence of lipolysis on drug absorption from the gastro-intestinal tract MacGregor, Karen J.
 1997
 82-83 1 p. 33-46
14 p.
 artikel
196 Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Hörter, D.
 1997
 82-83 1 p. 3-14
12 p.
 artikel
197 Inhalation therapy with recombinant human deoxyribonuclease I Gonda, Igor
 1996
 82-83 1 p. 37-46
10 p.
 artikel
198 Inorganic nanosystems for therapeutic delivery: Status and prospects Kim, Chang Soo
 2013
 82-83 1 p. 93-99
7 p.
 artikel
199 Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays Hegedűs, Csilla
 2009
 82-83 1 p. 47-56
10 p.
 artikel
200 Intracellular partitioning of cell organelles and extraneous nanoparticles during mitosis Symens, Nathalie
 2012
 82-83 1 p. 78-94
17 p.
 artikel
201 Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells Watson, Peter
 2005
 82-83 1 p. 43-61
19 p.
 artikel
202 Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy Tozer, Gillian M.
 2005
 82-83 1 p. 135-152
18 p.
 artikel
203 Introduction and overview of noninvasive drug monitoring Wolf, Walter
 2000
 82-83 1 p. 1-5
5 p.
 artikel
204 Introduction: Targeting of drugs and delivery systems Moghimi, S.M.
 1995
 82-83 1 p. 1-3
3 p.
 artikel
205 In vitro and in vivo models for assessing drug efflux transporter activity Zhang, Yan
 2003
 82-83 1 p. 31-51
21 p.
 artikel
206 In vivo efficacy and safety of skin electroporation Vanbever, Rita
 1999
 82-83 1 p. 77-88
12 p.
 artikel
207 In vivo gene delivery by electroporation Jaroszeski, Mark J
 1999
 82-83 1 p. 131-137
7 p.
 artikel
208 In vivo monitoring of drugs using radiotracer techniques Saleem, Azeem
 2000
 82-83 1 p. 21-39
19 p.
 artikel
209 Key issues in non-viral gene delivery Pouton, Colin W
 1998
 82-83 1 p. 3-19
17 p.
 artikel
210 Lessons from innovation in drug-device combination products Couto, Daniela S.
 2012
 82-83 1 p. 69-77
9 p.
 artikel
211 Lipid-based vehicles for the oral delivery of poorly water soluble drugs Humberstone, Andrew J.
 1997
 82-83 1 p. 103-128
26 p.
 artikel
212 Lipid fusion in oligonucleotide and gene delivery with cationic lipids Mönkkönen, Jukka
 1998
 82-83 1 p. 37-49
13 p.
 artikel
213 Liposomal DNA vectors for cystic fibrosis gene therapy. Current applications, limitations, and future directions Schreier, Hans
 1996
 82-83 1 p. 73-87
15 p.
 artikel
214 Liposomal drug delivery systems: From concept to clinical applications Allen, Theresa M.
 2013
 82-83 1 p. 36-48
13 p.
 artikel
215 Liposome ocular delivery systems Meisner, Dale
 1995
 82-83 1 p. 75-93
19 p.
 artikel
216 Liposomes for photodynamic therapy Derycke, Annelies S.L.
 2004
 82-83 1 p. 17-30
14 p.
 artikel
217 Live bacterial vectors for mucosal immunization Lintermans, P.
 1995
 82-83 1 p. 73-89
17 p.
 artikel
218 Lymphatic targeting with nanoparticulate system Nishioka, Yukiko
 2001
 82-83 1 p. 55-64
10 p.
 artikel
219 Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents Alving, Carl R.
 1988
 82-83 1 p. 107-128
22 p.
 artikel
220 Macrophages as targets for drug delivery Gordon, Siamon
 1989
 82-83 1 p. 27-47
21 p.
 artikel
221 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Schinkel, Alfred H
 2003
 82-83 1 p. 3-29
27 p.
 artikel
222 Mechanisms of drug release from cyclodextrin complexes Stella, Valentino J.
 1999
 82-83 1 p. 3-16
14 p.
 artikel
223 Mechanisms of electrochemotherapy Mir, Lluis M
 1999
 82-83 1 p. 107-118
12 p.
 artikel
224 Mechanisms of enveloped virus entry into animal cells Klasse, Per Johan
 1998
 82-83 1 p. 65-91
27 p.
 artikel
225 Mechanisms of macromolecule absorption by the lungs Patton, John S.
 1996
 82-83 1 p. 3-36
34 p.
 artikel
226 Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents Moghimi, S.M.
 1995
 82-83 1 p. 103-115
13 p.
 artikel
227 Mechanistic studies of molecular transdermal transport due to skin electroporation Pliquett, Uwe
 1999
 82-83 1 p. 41-60
20 p.
 artikel
228 Microemulsion-based media as novel drug delivery systems Lawrence, M.Jayne
 2000
 82-83 1 p. 89-121
33 p.
 artikel
229 Microspheres and nanoparticles used in ocular delivery systems Zimmer, Andreas
 1995
 82-83 1 p. 61-73
13 p.
 artikel
230 Molecular imprinting within hydrogels Byrne, Mark E
 2002
 82-83 1 p. 149-161
13 p.
 artikel
231 Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy Griffiths, John R
 2000
 82-83 1 p. 75-89
15 p.
 artikel
232 Mucoadhesive nanoparticulate systems for peptide drug delivery Takeuchi, Hirofumi
 2001
 82-83 1 p. 39-54
16 p.
 artikel
233 Mucosal delivery of vaccine antigens and its advantages in pediatrics De Magistris, Maria Teresa
 2006
 82-83 1 p. 52-67
16 p.
 artikel
234 Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides Couvreur, Patrick
 1997
 82-83 1 p. 85-96
12 p.
 artikel
235 Nanoparticle drug delivery system for restenosis Labhasetwar, Vinod
 1997
 82-83 1 p. 63-85
23 p.
 artikel
236 Nanoparticles in drug delivery: Past, present and future Couvreur, P.
 2013
 82-83 1 p. 21-23
3 p.
 artikel
237 Nanoparticulate systems for brain delivery of drugs Kreuter, Jörg
 2001
 82-83 1 p. 65-81
17 p.
 artikel
238 Nanoparticulate systems for improved drug delivery Kawashima, Yoshiaki
 2001
 82-83 1 p. 1-2
2 p.
 artikel
239 Nanoparticulate systems for the delivery of antisense oligonucleotides Lambert, Gregory
 2001
 82-83 1 p. 99-112
14 p.
 artikel
240 Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells Vinogradov, Serguei V
 2002
 82-83 1 p. 135-147
13 p.
 artikel
241 Nanosuspensions as particulate drug formulations in therapy Müller, R.H
 2001
 82-83 1 p. 3-19
17 p.
 artikel
242 Needle-free vaccine delivery Giudice, Erin L.
 2006
 82-83 1 p. 68-89
22 p.
 artikel
243 New advances in microsphere-based single-dose vaccines Hanes, Justin
 1997
 82-83 1 p. 97-119
23 p.
 artikel
244 New developments and opportunities in oral mucosal drug delivery for local and systemic disease Hearnden, Vanessa
 2012
 82-83 1 p. 16-28
13 p.
 artikel
245 Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors Dowell, James A
 2000
 82-83 1 p. 111-126
16 p.
 artikel
246 Non-parenteral vaccines Li Wan Po, A.
 1995
 82-83 1 p. 1-3
3 p.
 artikel
247 Nonviral delivery of genetic medicine for therapeutic angiogenesis Park, Hyun-Ji
 2012
 82-83 1 p. 40-52
13 p.
 artikel
248 [No title] Lee, Vincent H.L.
 2013
 82-83 1 p. 1-2
2 p.
 artikel
249 Novel approaches to pediatric vaccine delivery O'Hagan, Derek T.
 2006
 82-83 1 p. 29-51
23 p.
 artikel
250 Novel crosslinking methods to design hydrogels Hennink, W.E
 2002
 82-83 1 p. 13-36
24 p.
 artikel
251 Novel non-endocytic delivery of antisense oligonucleotides Dokka, Sujatha
 2000
 82-83 1 p. 35-49
15 p.
 artikel
252 Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye Zeimer, R
 2001
 82-83 1 p. 49-61
13 p.
 artikel
253 Nuclear imaging methods for non-invasive drug monitoring Bhatnagar, Anish
 2000
 82-83 1 p. 41-54
14 p.
 artikel
254 Nuclear import of polypeptides, polynucleotides and supramolecular complexes Pouton, Colin W
 1998
 82-83 1 p. 51-64
14 p.
 artikel
255 Nutrient transport across the placenta Knipp, Gregory T
 1999
 82-83 1 p. 41-58
18 p.
 artikel
256 Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate Zinn, Manfred
 2001
 82-83 1 p. 5-21
17 p.
 artikel
257 Ocular absorption following topical delivery Järvinen, Kristiina
 1995
 82-83 1 p. 3-19
17 p.
 artikel
258 Ocular drug delivery conventional ocular formulations Lang, John C.
 1995
 82-83 1 p. 39-43
5 p.
 artikel
259 Ocular inserts for topical delivery Saettone, Marco Fabrizio
 1995
 82-83 1 p. 95-106
12 p.
 artikel
260 One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate Okada, Hiroaki
 1997
 82-83 1 p. 43-70
28 p.
 artikel
261 Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines Wise, Donald L.
 1987
 82-83 1 p. 19-40
22 p.
 artikel
262 Opportunities in targeted drug delivery to Kupffer cells: delivery of immunomodulators to Kupffer cells-activation of tumoricidal properties Daemen, Toos
 1995
 82-83 1 p. 21-30
10 p.
 artikel
263 Particle control of emulsion by membrane emulsification and its applications Nakashima, Tadao
 2000
 82-83 1 p. 47-56
10 p.
 artikel
264 Pathological influences on colonic motility: implications for drug delivery Barrow, L.
 1991
 82-83 1 p. 201-218
18 p.
 artikel
265 PEG-uricase in the management of treatment-resistant gout and hyperuricemia Sherman, Merry R.
 2008
 82-83 1 p. 59-68
10 p.
 artikel
266 PEGylation of cyanovirin–N, an entry inhibitor of HIV Zappe, H.
 2008
 82-83 1 p. 79-87
9 p.
 artikel
267 Peptide and protein PEGylation III: advances in chemistry and clinical applications Veronese, Francesco M.
 2008
 82-83 1 p. 1-2
2 p.
 artikel
268 Peptide transport and metabolism across the placenta Chandorkar, Gurudatt A
 1999
 82-83 1 p. 59-67
9 p.
 artikel
269 Peroral administration of nanoparticles Kreuter, Jörg
 1991
 82-83 1 p. 71-86
16 p.
 artikel
270 Perspective from the founding editors Juliano, Rudy
 2013
 82-83 1 p. 3-4
2 p.
 artikel
271 Perspectives in drug and gene targeting with glycoproteins and other macromolecular carriers Meijer, Dirk K.F.
 1994
 82-83 1 p. v-vi
nvt p.
 artikel
272 Perspectives on the interface of drug delivery and tissue engineering Ekenseair, Adam K.
 2013
 82-83 1 p. 89-92
4 p.
 artikel
273 Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives Basak, Arup K.
 2007
 82-83 1 p. 1-2
2 p.
 artikel
274 Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications Basak, Arup K.
 2007
 82-83 1 p. 64-72
9 p.
 artikel
275 Pharmacokinetic considerations for targeted drug delivery Yamashita, Fumiyoshi
 2013
 82-83 1 p. 139-147
9 p.
 artikel
276 Pharmacokinetic considerations in local drug delivery Daemen, M.J.A.P.
 1991
 82-83 1 p. 1-18
18 p.
 artikel
277 Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery Tojo, Kakuji
 2001
 82-83 1 p. 17-24
8 p.
 artikel
278 Pharmacological research in pediatrics: From neonates to adolescents Rakhmanina, Natella Y.
 2006
 82-83 1 p. 4-14
11 p.
 artikel
279 Photochemical internalisation in drug and gene delivery Høgset, Anders
 2004
 82-83 1 p. 95-115
21 p.
 artikel
280 Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters Lopez, Renata Fonseca Vianna
 2004
 82-83 1 p. 77-94
18 p.
 artikel
281 Photosensitizer-antibody conjugates for detection and therapy of cancer van Dongen, G.A.M.S
 2004
 82-83 1 p. 31-52
22 p.
 artikel
282 Photosensitizer delivery for photodynamic therapy of choroidal neovascularization Renno, Reem Z.
 2001
 82-83 1 p. 63-78
16 p.
 artikel
283 Physics and instrumentation for imaging in-vivo drug distribution Singh, Manbir
 2000
 82-83 1 p. 7-20
14 p.
 artikel
284 Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice Vlaming, Maria L.H.
 2009
 82-83 1 p. 14-25
12 p.
 artikel
285 Places of emulsions in drug delivery Nakano, Masahiro
 2000
 82-83 1 p. 1-4
4 p.
 artikel
286 Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier Kabanov, Alexander V.
 2003
 82-83 1 p. 151-164
14 p.
 artikel
287 Polymer–drug conjugates: Origins, progress to date and future directions Kopeček, Jindřich
 2013
 82-83 1 p. 49-59
11 p.
 artikel
288 Polymeric endoluminal gel paving: hydrogel systems for local barrier creation and site-specific drug delivery Slepian, Marvin J.
 1997
 82-83 1 p. 11-30
20 p.
 artikel
289 Polymeric materials for advanced drug delivery 2001
 82-83 1 p. 1-3
3 p.
 artikel
290 Polymeric micelles to deliver photosensitizers for photodynamic therapy van Nostrum, Cornelus F
 2004
 82-83 1 p. 9-16
8 p.
 artikel
291 Polymer therapeutics-prospects for 21st century: The end of the beginning Duncan, Ruth
 2013
 82-83 1 p. 60-70
11 p.
 artikel
292 Polysaccharide colloidal particles as delivery systems for macromolecules Janes, K.A.
 2001
 82-83 1 p. 83-97
15 p.
 artikel
293 Potential applications and delivery strategies for bone morphogenetic proteins Kirker-Head, Carl A
 2000
 82-83 1 p. 65-92
28 p.
 artikel
294 Preface 2003
 82-83 1 p. 1-
1 p.
 artikel
295 Preface Suryanarayanan, R.
 2001
 82-83 1 p. 1-2
2 p.
 artikel
296 Preface 2002
 82-83 1 p. 1-
1 p.
 artikel
297 Preface Schoenwald, Ronald D.
 1995
 82-83 1 p. 1-
1 p.
 artikel
298 Preface Levy, Robert J.
 1997
 82-83 1 p. 1-
1 p.
 artikel
299 Preface Niven, Ralph
 1997
 82-83 1 p. 1-2
2 p.
 artikel
300 Preface Okada, Hiroaki
 1997
 82-83 1 p. 1-3
3 p.
 artikel
301 Preface Swaan, Peter W.
 1996
 82-83 1 p. 1-3
3 p.
 artikel
302 Preface 2000
 82-83 1 p. 1-
1 p.
 artikel
303 Preface Fons, Michael P.
 1996
 82-83 1 p. 1-2
2 p.
 artikel
304 Preface Davidson, Beverly L
 1997
 82-83 1 p. 1-4
4 p.
 artikel
305 Preface Audus, Kenneth L
 1999
 82-83 1 p. 1-
1 p.
 artikel
306 Preface Akhtar, Saghir
 2000
 82-83 1 p. 1-
1 p.
 artikel
307 Preface Tomlinson, E.
 1992
 82-83 1 p. vii-
1 p.
 artikel
308 Preface Friend, David R.
 1991
 82-83 1 p. vii-
1 p.
 artikel
309 Preface Tomlinson, E.
 1991
 82-83 1 p. vii-
1 p.
 artikel
310 Preface Pitt, C.G.
 1993
 82-83 1 p. vii-
1 p.
 artikel
311 Preface Juliano, R.J.
 1988
 82-83 1 p. v-
1 p.
 artikel
312 Preface Wilson, Glynn
 1989
 82-83 1 p. v-vi
nvt p.
 artikel
313 Preface Bundgaard, H
 1989
 82-83 1 p. v-
1 p.
 artikel
314 Preface 1987
 82-83 1 p. v-vi
nvt p.
 artikel
315 Preface Pulmonary (poly)peptide and (poly)nucleic acid delivery Schreier, Hans
 1996
 82-83 1 p. 1-2
2 p.
 artikel
316 Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin Fukushima, Shoji
 2000
 82-83 1 p. 65-75
11 p.
 artikel
317 Preparation and evaluation of w/o/w type emulsions containing vancomycin Okochi, Hideaki
 2000
 82-83 1 p. 5-26
22 p.
 artikel
318 Preparation of microspheres by the solvent evaporation technique O'Donnell, Patrick B
 1997
 82-83 1 p. 25-42
18 p.
 artikel
319 Preparation of peptide and protein powders for inhalation Johnson, Keith A
 1997
 82-83 1 p. 3-15
13 p.
 artikel
320 Prodrugs for dermal delivery Sloan, Kenneth B
 1989
 82-83 1 p. 67-101
35 p.
 artikel
321 Prodrugs for improved ocular drug delivery Lee, Vincent H.L
 1989
 82-83 1 p. 1-38
38 p.
 artikel
322 Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis Glorioso, Joseph C.
 1997
 82-83 1 p. 41-57
17 p.
 artikel
323 Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products Kruhlak, Naomi L.
 2007
 82-83 1 p. 43-55
13 p.
 artikel
324 Protein delivery by microencapsulated cells Uludag, Hasan
 1993
 82-83 1 p. 115-130
16 p.
 artikel
325 Pulmonary delivery of therapeutic siRNA Lam, Jenny Ka-Wing
 2012
 82-83 1 p. 1-15
15 p.
 artikel
326 Pulsatile drug release control using hydrogels Kikuchi, Akihiko
 2002
 82-83 1 p. 53-77
25 p.
 artikel
327 Purification and structural analyses of ABCG2 McDevitt, Christopher A.
 2009
 82-83 1 p. 57-65
9 p.
 artikel
328 QSAR analysis and molecular modeling of ABCG2-specific inhibitors Nicolle, E.
 2009
 82-83 1 p. 34-46
13 p.
 artikel
329 Quality control of human ABCG2 protein in the endoplasmic reticulum: Ubiquitination and proteasomal degradation Wakabayashi-Nakao, Kanako
 2009
 82-83 1 p. 66-72
7 p.
 artikel
330 Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LH-RH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditions Schally, Andrew V.
 1997
 82-83 1 p. 157-169
13 p.
 artikel
331 Real-time multiple-particle tracking: applications to drug and gene delivery Suh, Junghae
 2005
 82-83 1 p. 63-78
16 p.
 artikel
332 Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals van Drunen Littel-van den Hurk, Sylvia
 2000
 82-83 1 p. 13-28
16 p.
 artikel
333 Receptor-mediated delivery of drugs to hepatocytes Fallon, Robert J.
 1989
 82-83 1 p. 49-63
15 p.
 artikel
334 Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development 1 This manuscript is dedicated to the memory of Dr. Michael J. Cronin. Dr. Cronin was a brilliant endocrine scientist with an incredible ability to objectively evaluate any problem, no matter how complex. His spirit and knowledge contributed to the success of the work described herein and his wisdom continues to guide those of us fortunate enough to have known him. 1 Cleland, Jeffrey L
 1997
 82-83 1 p. 71-84
14 p.
 artikel
335 Releasable PEGylation of proteins with customized linkers Filpula, David
 2008
 82-83 1 p. 29-49
21 p.
 artikel
336 Responsive hydrophobically associating polymers: a review of structure and properties Tonge, S.R
 2001
 82-83 1 p. 109-122
14 p.
 artikel
337 Responsive polymeric delivery systems Joseph, Kost
 1991
 82-83 1 p. 19-50
32 p.
 artikel
338 Retrometabolic drug design concepts in ophthalmic target-specific drug delivery Bodor, Nicholas
 1995
 82-83 1 p. 21-38
18 p.
 artikel
339 Review of dry powder inhalers Prime, David
 1997
 82-83 1 p. 51-58
8 p.
 artikel
340 Ribozyme therapy for HIV infection Rossi, John J
 2000
 82-83 1 p. 71-78
8 p.
 artikel
341 Role of engineered nanocarriers for axon regeneration and guidance: Current status and future trends GhoshMitra, Somesree
 2012
 82-83 1 p. 110-125
16 p.
 artikel
342 Selecting optimal antisense reagents Sohail, M
 2000
 82-83 1 p. 23-34
12 p.
 artikel
343 Self-amplifying vectors for gene delivery Herweijer, Hans
 1997
 82-83 1 p. 5-16
12 p.
 artikel
344 Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase Fontana, Angelo
 2008
 82-83 1 p. 13-28
16 p.
 artikel
345 Solubilisation of hydrophilic drugs in oily formulations New, Roger R.C.
 1997
 82-83 1 p. 59-69
11 p.
 artikel
346 Soluble polymers for lectin-mediated drug targeting Seymour, Len W.
 1994
 82-83 1 p. 89-111
23 p.
 artikel
347 Some biological issues in oral, controlled drug delivery Gruber, Peter
 1987
 82-83 1 p. 1-18
18 p.
 artikel
348 Stimuli-responsive polymers: Biomedical applications and challenges for clinical translation Hoffman, Allan S.
 2013
 82-83 1 p. 10-16
7 p.
 artikel
349 Strategies for the investigation and control of process-related impurities in drug substances Argentine, Mark D.
 2007
 82-83 1 p. 12-28
17 p.
 artikel
350 Structure and function of gastro-intestinal lipases Embleton, Jonathan K.
 1997
 82-83 1 p. 15-32
18 p.
 artikel
351 Studying biophysical barriers to DNA delivery by advanced light microscopy De Smedt, S.C.
 2005
 82-83 1 p. 191-210
20 p.
 artikel
352 Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Storm, Gert
 1995
 82-83 1 p. 31-48
18 p.
 artikel
353 Targeted delivery of low molecular drugs using chitosan and its derivatives Park, Jae Hyung
 2010
 82-83 1 p. 28-41
14 p.
 artikel
354 Targeted photodynamic therapy via receptor mediated delivery systems Sharman, Wesley M.
 2004
 82-83 1 p. 53-76
24 p.
 artikel
355 Targeting of antiviral drugs to the liver using glycoprotein carriers Fiume, L.
 1994
 82-83 1 p. 51-65
15 p.
 artikel
356 Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics Hawley, A.E.
 1995
 82-83 1 p. 129-148
20 p.
 artikel
357 Targeting of drugs and drug carriers within the cardiovascular system Torchilin, Vladimir P.
 1995
 82-83 1 p. 75-101
27 p.
 artikel
358 Targeting of drugs to various blood cell types using (neo-)glycoproteins, antibodies and other protein carriers Molema, G.
 1994
 82-83 1 p. 25-50
26 p.
 artikel
359 Targeting of genes to the liver with glycoprotein carriers Frese Jr., John
 1994
 82-83 1 p. 137-152
16 p.
 artikel
360 Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer Fidler, Isaiah J.
 1988
 82-83 1 p. 69-106
38 p.
 artikel
361 Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances Xu, Shi
 2013
 82-83 1 p. 121-138
18 p.
 artikel
362 Targeting solid tumours: challenges, disappointments, and opportunities Murray, J.C.
 1995
 82-83 1 p. 117-127
11 p.
 artikel
363 Techniques to study human placental transport Sastry, B.V.Rama
 1999
 82-83 1 p. 17-39
23 p.
 artikel
364 The common mucosal immune system for the reproductive tract: basic principles applied toward an AIDS vaccine Kiyono, Hiroshi
 1995
 82-83 1 p. 23-52
30 p.
 artikel
365 The conjugation of proteins with polyethylene glycol and other polymers Katre, Nandini V.
 1993
 82-83 1 p. 91-114
24 p.
 artikel
366 The delivery of antisense therapeutics Akhtar, Saghir
 2000
 82-83 1 p. 3-21
19 p.
 artikel
367 The double prodrug concept and its applications Bundgaard, Hans
 1989
 82-83 1 p. 39-65
27 p.
 artikel
368 The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteries Humphrey, William R.
 1997
 82-83 1 p. 87-108
22 p.
 artikel
369 The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Maeda, Hiroshi
 2013
 82-83 1 p. 71-79
9 p.
 artikel
370 The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges Gans-Brangs, Kathleen R.
 2006
 82-83 1 p. 106-115
10 p.
 artikel
371 The expression and regulation of drug metabolism in human placenta Pasanen, Markku
 1999
 82-83 1 p. 81-97
17 p.
 artikel
372 The importance of gastrointestinal uptake of particles in the design of oral delivery systems Lavelle, E.C.
 1995
 82-83 1 p. 5-22
18 p.
 artikel
373 The intestinal peptide carrier: A potential transport system for small peptide derived drugs Walter, Elke
 1996
 82-83 1 p. 33-58
26 p.
 artikel
374 Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes Morris, Kenneth R.
 2001
 82-83 1 p. 91-114
24 p.
 artikel
375 Theory of electrical creation of aqueous pathways across skin transport barriers Weaver, James C
 1999
 82-83 1 p. 21-39
19 p.
 artikel
376 The potential of oily formulations for drug delivery to the gastro-intestinal tract Pouton, Colin W.
 1997
 82-83 1 p. 1-2
2 p.
 artikel
377 The potential use of receptor-mediated endocytosis for oral drug delivery Russell-Jones, G.J.
 1996
 82-83 1 p. 83-97
15 p.
 artikel
378 Therapeutic applications of viscous and injectable poly(ortho esters) Einmahl, Suzanne
 2001
 82-83 1 p. 45-73
29 p.
 artikel
379 Therapeutic effects of leuprorelin microspheres in prostate cancer Sharifi, Roohollah
 1997
 82-83 1 p. 121-138
18 p.
 artikel
380 Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata Miller, James D
 1997
 82-83 1 p. 139-155
17 p.
 artikel
381 The rhythmic organization of the immune network: implications for the chronopharmacologic delivery of interferons, interleukins and cyclosporin Lévi, F.
 1992
 82-83 1 p. 85-112
28 p.
 artikel
382 Thermosensitive sol–gel reversible hydrogels Jeong, Byeongmoon
 2002
 82-83 1 p. 37-51
15 p.
 artikel
383 The role of degradant profiling in active pharmaceutical ingredients and drug products Alsante, Karen M.
 2007
 82-83 1 p. 29-37
9 p.
 artikel
384 The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy Ishikawa, Toshihisa
 2009
 82-83 1 p. 1-2
2 p.
 artikel
385 The role of γ-scintigraphy in oral drug delivery Wilding, I.R.
 1991
 82-83 1 p. 87-117
31 p.
 artikel
386 Tight junction modulation and its relationship to drug delivery Salama, Noha N.
 2006
 82-83 1 p. 15-28
14 p.
 artikel
387 Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels Zignani, M.
 1995
 82-83 1 p. 51-60
10 p.
 artikel
388 Toxicity of drug carriers to the mononuclear phagocyte system Allen, T.M.
 1988
 82-83 1 p. 55-67
13 p.
 artikel
389 Toxicological overview of impurities in pharmaceutical products Jacobson-Kram, David
 2007
 82-83 1 p. 38-42
5 p.
 artikel
390 Transcutaneous immunization of domestic animals: opportunities and challenges Hammond, Scott A.
 2000
 82-83 1 p. 45-55
11 p.
 artikel
391 Transdermal delivery of antisense compounds Brand, R.M
 2000
 82-83 1 p. 51-57
7 p.
 artikel
392 Transplacental drug delivery: gene and virus delivery to the trophoblast Parry, Samuel
 1999
 82-83 1 p. 69-80
12 p.
 artikel
393 Transport of lipophilic molecules by the intestinal lymphatic system Charman, W.N.
 1991
 82-83 1 p. 1-14
14 p.
 artikel
394 Transscleral drug delivery for posterior segment disease Geroski, Dayle H
 2001
 82-83 1 p. 37-48
12 p.
 artikel
395 Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis Golomb, Gershon
 1997
 82-83 1 p. 53-62
10 p.
 artikel
396 Uptake of drugs into the intestinal lymphatics after oral administration Porter, Christopher J.H.
 1997
 82-83 1 p. 71-89
19 p.
 artikel
397 Use of fluorescence imaging to investigate the structure and function of intestinal M cells Buda, Andrea
 2005
 82-83 1 p. 123-134
12 p.
 artikel
398 Use of the herpes amplicon system as a vehicle for somatic gene transfer Brooks, Andrew I
 1997
 82-83 1 p. 29-39
11 p.
 artikel
399 Use of the intestinal and hepatic bile acid transporters for drug delivery Swaan, Peter W.
 1996
 82-83 1 p. 59-82
24 p.
 artikel
                             399 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland